기업 프로필 · Healthcare

Cardinal Health Inc

CAH · 미국
거래소
미국
국가 / 지역
USA
상장일
1987년 12월 31일
직원 수
53,084
현재가
$221.77
실시간 · 2026년 6월 18일
베일리 성장 점수
41/100
다소 약함
내재가치 · 3단계 구간 현재가 $221.77 실시간 · 적정 구간과 낙관적 구간 사이

종합 밸류에이션 구간 · 보수적 $130–$160 / 적정 $175–$215 / 낙관적 $240–$300. $221.77 기준, 적정 구간과 낙관적 구간 사이.

보고서 발행 시 $200.68(2026년 5월 24일)

이 종목에 대한 리포트가 아직 해당 언어로 없습니다.

Cardinal Health, Inc. operates as a healthcare services and products company in the United States and internationally. It operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. The company provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. It distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The company also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; pharmacy management services to hospitals; operates pharmacies, including pharmacies in community health centers; and repackages generic pharmaceuticals and over-the-counter healthcare products. In addition, it manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compression, incontinence, nutritional delivery, and wound care products; single-use surgical drapes, gowns, and apparel products; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. Further, the company distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile and non-sterile procedure kits. Additionally, it manufactures, prepares, and delivers radiopharmaceuticals; and optimizes direct shipments through integrated technology solutions. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.

시가총액US$529.96억
매출 (TTM)US$2507.35억
EBITDAUS$39.94억
순이익률0.62%
ROE0%
PER (TTM)34.6
선행 PER19.05
PEG1.4
EPSUS$6.54
배당수익률0.9%
52주 범위US$136.63 – US$233.04
애널리스트 목표주가US$245.27
애널리스트 평가4.1 / 5

데이터 제공: EODHD, 보고 통화 기준 표시. 참고용일 뿐 투자 자문이 아닙니다.

연혁

준비 중이 섹션은 작성 중입니다. 곧 다시 확인해 주세요.

업계 내 위치

준비 중이 섹션은 작성 중입니다. 곧 다시 확인해 주세요.